Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022154

TYZEKA (TELBIVUDINE)
100MG/5ML Marketing Status: Discontinued

Active Ingredient: TELBIVUDINE
Proprietary Name: TYZEKA
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: 100MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N022154
Product Number: 001
Approval Date: Apr 28, 2009
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English